Results from the CHOICE-2 trial show a 15% absolute increase in excellent functional outcomes with intra-arterial alteplase ...

Apollo Specialty Hospitals in Tiruchi launches advanced CT perfusion scan and stroke command centre for enhanced stroke care ...

Understand why routine lactate rechecks every 3–4 hours for days, prompting more fluids and vasopressors, can worsen outcomes ...

Johns Hopkins scientists and partners across the country are conducting research that could dramatically improve transplants, ...

Rapid Medical announces DISTALS trial results showing TIGERTRIEVER 13 achieved superior brain reperfusion with strong safety in MVO ischemic stroke.

Rapid Medicaltm, a leading developer of active endovascular devices, today announced late-breaking results from the DISTALS multicenter, randomized controlled trial showing that TIGERTRIEVERtm 13 ...

A landmark trilogy of scientific studies, published today on the preprints.org server, has for the first time comprehensively characterised the anomalous intravascular casts (AICs) commonly reported ...

Scientists have taken a decisive step toward ending one of transplant medicine’s most stubborn bottlenecks: the need to match donor organs to a recipient’s blood type. By chemically reengineering a ...

The ability to restore light responses in human retinas postmortem offers a novel model for studying retinal recovery and ...

Predicting how circulating immune cells interact with human tissues remains a major challenge in preclinical drug testing. Traditional static culture ...

TIGERTRIEVER 13 is the first device shown to meet safety and effectiveness endpoints for restoring blood flow in smaller but critical areas of the brain, accounting for almost 50% of all ischemic stro ...

United Therapeutics Corporation uses strong cash flows to develop xenotransplanted organs and solve global supply shortages.